Comparing the effects of metformin versus combined Contraceptive pills in adolescent PCOS

Metformin versus combined oral contraceptives in adolescent PCOS through a 24 months follow up period : a randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201307000567163

Enrollment

120

Registered

2013-06-18

Start date

2010-02-15

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional, Metabolic, Endocrine Fertility-female Polycystic ovarian syndrome

Interventions

Metformin group

OCPs

Control

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: hirsutism acne menstrual disturbances. oligomenorrhea (1 µg/ml

Exclusion criteria

Exclusion criteria: Suprarenal dysfunction hyperprolactinaemia thyroid dysfunction or recent intake of medications likely to affect hormonal profile

Design outcomes

Primary

Measure	Time frame
improvement in fasting serum insulin levels, and Glucose/Insulin ratio;reduction in serum testosterone levels	—

Secondary

Measure	Time frame
improvement in cycle rhythm ;hirsutism;weight loss	—

Countries

Egypt

Contacts

Public ContactElsayedamr Basma

Patient Information Manager

elsayedamr@yahoo.com00201223106023

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026